Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate

NEXT STORY
Global Neurological Therapies Market Research Report 2021: Competitive Landscape and Pipeline Analysis Focusing Specifically on Therapeutic Interventions for Neurodegenerative Diseases
PREV STORY
atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

INVENTIVA Announces a U.S. Phase II Investigator-Initiated Study with Lanifibranor on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes

author_avatar
NASDAQ Market News

Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members

author_avatar
NASDAQ Market News

Drayson Health Announces Positive Clinical Trial Results with GDm-Health(TM), its Digital Therapeutic Product Powered by Smart Algorithms for the Treatment of Gestational Diabetes

  PRESS RELEASE   Drayson Health in collaboration with the University of Oxford and ...

author_avatar
NASDAQ Market News